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Background
It has been reported for over the past decade that the use
of selective serotonin reuptake inhibitors (SSRIs) may
associate with the emergence of apathy. The authors
hypothesized that depressed patients treated with SSRIs
would show more signs of apathy than patients treated
with non-SSRI antidepressants. This case control study
was conducted to investigate the possibility of the associ-
ation between SSRI use and the occurrence of apathy.
Materials and methods
Baycrest Centre for Geriatric Care's Day Hospital Database
of elderly depressed patients who received antidepressants
was divided into 2 groups depending on antidepressant
use at discharge: SSRI user group-SUG, and non-SSRI user
group-NSUG. Apathy scales developed by the authors
were selected from the Geriatric Depression Scale (GDS)
and the Hamilton Rating Scale for Depression (HAMD),
and were titled as GDS-apathy subscale (GAS) and
HAMD-apathy subscale (HAS). Demographic data, base-
line apathy, underlying medical conditions and medica-
tion use were studied. Proportion, analysis of variances,
Chi-square test, odds ratio with 95% confidence interval
were reported.
Results
Among 384 patients (160 SUG and 224 NSUG), mean
GDS and HAM-D at discharge were 12.46 and 10.61 in
SUG, and were 11.37 and 9.30 in NSUG, respectively.
Using GAS for apathy assessment, 83.7% of patients in
SUG and 73.4% in NSUG stayed apathetic at discharge. As
evaluated by HAS, 44.2% of patients in SUG and 36.5%
in NSUG stayed apathetic. SSRI use was not a predictor of
apathy at admission, while it was at discharge, p = 0.029.
The SUG showed more patients with apathy than that
found in NSUG (adjusted OR = 1.90 (1.14–3.17). Age 70–
75 years tended to be a predictor for the apathy (p =
0.058). Using HAS, age 70–75 years and living situation
were associated with apathy at discharge, p = 0.032 and
0.038 respectively.
Discussion
Even though depression was improved in elderly patients
receiving antidepressants, apathy appeared to be greater in
patients who had history of SSRI use than that found in
patients who did not. Frontal lobe dysfunction due to
alteration of serotonin is considered to be one of the pos-
sibilities.
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